Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
Major depressive disorder (MDD) is a common psychiatric disorder with multifactorial aetiology and complex pathophysiology. Despite availability of various pharmacological and non-pharmacological therapeutic strategies, treatment resistant depression (TRD) remains a significant challenge with specif...
Guardado en:
Autor principal: | Naghmeh Nikkheslat |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2369bc529d63484dbb35b814e26d76e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunoregulation and antidepressant effect of ketamine
por: Zhang Nan, et al.
Publicado: (2021) -
Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Wei Zheng, et al.
Publicado: (2021) -
Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
por: F Kheirkhah, et al.
Publicado: (2010) -
EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
por: Muhammad Siddique Kakar, et al.
Publicado: (2020) -
Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
por: Mateusz Kowalczyk, et al.
Publicado: (2021)